ConexiantX Chromosome Loss Tied to Infertility

⚠️ Small Study / Early Comparative Evidence

Researchers quantified hematopoietic LOX burden via droplet digital PCR in 381 women with unexplained infertility and 123 natural-conception controls. LOX did not correlate with AMH or FSH, suggesting it may index a biologic aging dimension distinct from standard ovarian reserve markers.

Clinical Considerations

• Women above the 0.87% LOX threshold had more than twofold the odds of failing to conceive naturally; association was strongest in the 35–39 age group
• LOX showed no association with ART outcomes in 172 women undergoing IVF/ICSI, even after adjustment for age and AMH
• AUC of 0.60 indicates modest standalone discriminative performance — comparable to some existing ovarian reserve markers for natural conception prediction
• Proposed mechanisms include systemic genomic instability, shared genetic predisposition with reproductive decline, and immune dysregulation via altered leukocyte gene expression

Practice Applications

• Recognize LOX as a hypothesis-generating biomarker only; no clinical role is established for routine infertility workup
• Avoid interpreting LOX as a substitute for AMH or FSH — current evidence supports complementary framing at best
• Consider that findings apply to natural conception prediction, not ART counseling, where LOX showed no predictive value
• Monitor this space for prospective longitudinal data before incorporating somatic mosaicism markers into fertility discussions